CD19 and lymphoma: As CD19-Cre-mediated deletion of Mcl-1fl alleles was rather inefficient, we wanted to test whether deleting Mcl-1fl allele(s) more efficiently and at an earlier stage in B-cell development would have a greater impact in our lymphoma model.